Thomson Reuters

The Thomson Message Mapping System measures the potential impact of published scientific information on the clinical practices of healthcare professionals by ranking it in a way that reflects their selection and reading processes.

You can critically evaluate how the information published about your products, in scientific literature or at major medical meetings, supports or detracts from the key clinical concepts and messages associated with those products.

You can understand the role and impact of key scientific publications on clinical practices and ascertain how messages about your product are being perceived from the point of view of the prescribing clinician.

Measure and compare the potential impact of published scientific information.

With Thomson Message Mapping System, you can:

• Plan your research and publication strategies.
• Differentiate the position of your products in the market.
• Determine which messages are reaching your key target audience.
• Monitor the goals of your communications programs.
• Benchmark your product's messages against market leaders.
• Focus on literature that has a critical impact.
• Respond swiftly to competitive threats.
  

Why choose Thomson Message Mapping System?

• Medical affairs: Access critical information on the clinical themes, concepts, and messages that are being disseminated in scientific literature.
• Publications planning: Ensure manuscripts under development maximize the ROI from your communications budget.
• Marketing, branding and positioning: Obtain feedback on the strength, diversity, and value of the messages your target audience is receiving about your products.
• Competitive intelligence: Enhance your product positioning by receiving key intelligence about your competitors.
• Business development and licensing: Benefit from more than 60 tabular and graphic reports to guide and support investment, licensing, and other product and business development efforts.
• Regulatory affairs and clinical development: Access critical information that will inform the planning of clinical trials for products in development or pre-launch.